http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106188292-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 |
| filingDate | 2015-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106188292-B |
| titleOfInvention | Anti- CD4 protein monoclonal antibody and application thereof |
| abstract | The present invention relates to field of biotechnology, disclose a kind of hybridoma cell strain (deposit number is CGMCC No.9576), and the monoclonal antibody UMAB64 that thus hybridoma cell strain generates.The invention further relates to monoclonal antibody UMAB64 to prepare the application in the immune detection tool for detecting CD4 albumen, application of the immunohistochemical kit and monoclonal antibody UMAB64 of the UMAB64 containing monoclonal antibody in the kit that preparation is used for marked tumor.Monoclonal antibody of the present invention can in conjunction with CD4 protein-specific, and with other intracellular albumen no cross reactions, significantly improve specificity, the accuracy and reliability of the detection of CD4 protein immunization. |
| priorityDate | 2015-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.